header("Content-type: text/html; charset=iso-8859-1"); ?>
This webinar is second in the series discussing, Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug-Susceptible Tuberculosis Guidelines: Caveats and Controversies.
© 2017, Rutgers, The State University of New Jersey. All rights reserved.
225 Warren Street, Newark, New Jersey 07103